title: Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay.
abstract: F2-Isoprostanes are stable lipid peroxidation products of arachidonic acid, the quantification of which provides an index of oxidative stress in vivo. We describe a method for analysing isoprostaglandin F2alpha type III (15-F2t-IsoP) in biological fluids. The method involves solid-phase extraction on octadecyl endcapped and aminopropyl cartridges. After conversion to trimethylsilyl ester trimethylsilyl ether derivatives, isoprostaglandin F2alpha type III is analysed by mass spectrometry, operated in electronic impact selected ion monitoring mode. We have compared enzyme immunoassay (EIA; Cayman, Ann Arbor, MI, USA) to this method with 30 human urine aliquots following the same extraction procedure in order to determine the agreement between both methods. Isoprostaglandin F2alpha type III concentrations determined with gas chromatography-mass spectrometry (GC-MS) did not agree with those determined with EIA. Our results suggest that GC-MS and EIA do not measure the same compounds. As a consequence, comparison of clinical results using GC-MS and EIA should be avoided.
authors.affiliation: Laboratory of Pharmacology, Grenoble University Hospital, France. gbessard@chu-grenoble.fr
authors.forename: J
authors.initials: J
authors.lastname: Bessard
authors.forename: J L
authors.initials: JL
authors.lastname: Cracowski
authors.forename: F
authors.initials: F
authors.lastname: Stanke-Labesque
authors.forename: G
authors.initials: G
authors.lastname: Bessard
mesh_terms: D003429:Cross Reactions; D015237:Dinoprost / Q000031:analogs & derivatives / Q000652:urine*; D028441:F2-Isoprostanes; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods*; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D011786:Quality Control; D014662:Vasoconstrictor Agents / Q000652:urine
chemical_list: D028441:F2-Isoprostanes; D014662:Vasoconstrictor Agents; C075750:8-epi-prostaglandin F2alpha; D015237:Dinoprost